Liu J, Tokheim C, Lee J, Gan W, North B, Liu X
Nat Commun. 2021; 12(1):6704.
PMID: 34795215
PMC: 8602260.
DOI: 10.1038/s41467-021-26871-y.
Cerrato A, Morra F, Di Domenico I, Celetti A
Cancers (Basel). 2019; 12(1).
PMID: 31877762
PMC: 7016757.
DOI: 10.3390/cancers12010044.
Yamazaki M, Nakaseko C, Takeuchi M, Ozawa S, Ishizuka Y, Hatanaka Y
Intern Med. 2019; 58(23):3449-3453.
PMID: 31327842
PMC: 6928497.
DOI: 10.2169/internalmedicine.3220-19.
Valent P, Orazi A, Savona M, Patnaik M, Onida F, van de Loosdrecht A
Haematologica. 2019; 104(10):1935-1949.
PMID: 31048353
PMC: 6886439.
DOI: 10.3324/haematol.2019.222059.
Cerrato A, Visconti R, Celetti A
Mol Cancer. 2018; 17(1):46.
PMID: 29455670
PMC: 5817729.
DOI: 10.1186/s12943-018-0799-8.
FBXW7 and USP7 regulate CCDC6 turnover during the cell cycle and affect cancer drugs susceptibility in NSCLC.
Morra F, Luise C, Merolla F, Poser I, Visconti R, Ilardi G
Oncotarget. 2015; 6(14):12697-709.
PMID: 25885523
PMC: 4494967.
DOI: 10.18632/oncotarget.3708.
Discovery of imatinib-responsive FIP1L1-PDGFRA mutation during refractory acute myeloid leukemia transformation of chronic myelomonocytic leukemia.
Shah S, Loghavi S, Garcia-Manero G, Khoury J
J Hematol Oncol. 2014; 7:26.
PMID: 24669761
PMC: 3994268.
DOI: 10.1186/1756-8722-7-26.
Identification of sumoylation sites in CCDC6, the first identified RET partner gene in papillary thyroid carcinoma, uncovers a mode of regulating CCDC6 function on CREB1 transcriptional activity.
Luise C, Merolla F, Leone V, Paladino S, Sarnataro D, Fusco A
PLoS One. 2012; 7(11):e49298.
PMID: 23145146
PMC: 3492267.
DOI: 10.1371/journal.pone.0049298.
Loss of CCDC6, the first identified RET partner gene, affects pH2AX S139 levels and accelerates mitotic entry upon DNA damage.
Merolla F, Luise C, Muller M, Pacelli R, Fusco A, Celetti A
PLoS One. 2012; 7(5):e36177.
PMID: 22655027
PMC: 3360053.
DOI: 10.1371/journal.pone.0036177.
Loss of CCDC6 affects cell cycle through impaired intra-S-phase checkpoint control.
Thanasopoulou A, Stravopodis D, Dimas K, Schwaller J, Anastasiadou E
PLoS One. 2012; 7(2):e31007.
PMID: 22363533
PMC: 3281900.
DOI: 10.1371/journal.pone.0031007.
Diagnosis and management of chronic myelomonocytic leukemia.
Onida F, Beran M
Curr Hematol Malig Rep. 2010; 3(1):31-6.
PMID: 20425444
DOI: 10.1007/s11899-008-0006-x.
Differential 14-3-3 affinity capture reveals new downstream targets of phosphatidylinositol 3-kinase signaling.
Dubois F, Vandermoere F, Gernez A, Murphy J, Toth R, Chen S
Mol Cell Proteomics. 2009; 8(11):2487-99.
PMID: 19648646
PMC: 2773716.
DOI: 10.1074/mcp.M800544-MCP200.
PP4R4/KIAA1622 forms a novel stable cytosolic complex with phosphoprotein phosphatase 4.
Chen G, Tisayakorn S, Jorgensen C, DAmbrosio L, Goudreault M, Gingras A
J Biol Chem. 2008; 283(43):29273-84.
PMID: 18715871
PMC: 2662017.
DOI: 10.1074/jbc.M803443200.
